Andere talen BioPorto A/S

Aandelen

Vertraagde tijd Nasdaq Copenhagen Andere beurzen 15:46:45 03-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,31 ^DKK	+1,08%		+6,50%	-37,32%

10/04	BioPorto benoemt nieuwe Chief Legal Officer	MT
10/04	Bioporto A/S benoemt Gry Louise Husby Larsen tot Chief Legal Officer en lid van het Executive Management Team, met ingang van 15 april 2024	CI

Resolutions of Annual Geneal Meeting	30/04
Grant of warrants	23/04
BioPorto Names New Chief Legal Officer	10/04
BioPorto A/S Appoints Chief Legal Officer	10/04
Bioporto A/S Appoints Gry Louise Husby Larsen as Chief Legal Officer and Member of the Executive Management Team, Effective as of April 15, 2024	10/04
New Board Candidate for the upcoming Annual Geneal Meeting	05/04
Bioporto A/S Announces Tonni Bülow-Nielsennot to Stand for Election	05/04
Notice convening the Annual General Meeting in BioPorto A/S	04/04
Correction: BioPorto Announces Annual Results for 2023	04/04
BioPorto Announces Annual Results for 2023	04/04
BioPorto A/S Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
BioPorto Makes Interim CEO Permanent	02/04
BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer	02/04
BioPorto A/S Appoints Peter Mørch Eriksen as Permanent Group CEO	02/04
Bioporto A/S Announces Peter Mørch Eriksen Will Not Stand for Re-Election to the Board of Directors	02/04
BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026	22/02
BioPorto A/S Provides Revenue Guidance for the Full Year 2024	22/02
Roche : collaboration étendue avec le danois BioPorto	20/02
BioPorto Expands Global Distribution Partnership with Roche Diagnostics	20/02
Roche Diagnostics and BioPorto expand collaboration	20/02

Geen resultaten voor deze zoekopdracht